Astrana Health Files 8-K on Financial Results

Ticker: ASTH · Form: 8-K · Filed: Feb 27, 2024 · CIK: 1083446

Astrana Health, INC. 8-K Filing Summary
FieldDetail
CompanyAstrana Health, INC. (ASTH)
Form Type8-K
Filed DateFeb 27, 2024
Risk Levellow
Pages2
Reading Time2 min
Sentimentneutral

Sentiment: neutral

Topics: financial-results, 8-K, disclosure

Related Tickers: AMEH

TL;DR

**Astrana Health just filed an 8-K announcing its financial results, but the actual numbers aren't in this snippet.**

AI Summary

Astrana Health, Inc. (formerly Apollo Medical Holdings, Inc.) filed an 8-K on February 27, 2024, to report its "Results of Operations and Financial Condition" and to furnish "Financial Statements and Exhibits." This filing indicates the company is disclosing its latest financial performance, though the specific details and dollar amounts are not included in this excerpt.

Why It Matters

This 8-K signals Astrana Health's disclosure of its latest financial performance, providing investors with crucial information about the company's health and operational status, even though the specific figures are not detailed in this particular excerpt.

Risk Assessment

Risk Level: low — This 8-K is a routine disclosure of financial results; the risk depends on the undisclosed financial performance, not the filing itself.

Key Players & Entities

FAQ

What is the primary purpose of this 8-K filing by Astrana Health, Inc.?

The primary purpose of this 8-K filing is to report the company's "Results of Operations and Financial Condition" and to furnish "Financial Statements and Exhibits."

When was the earliest event reported in this 8-K?

The earliest event reported in this 8-K occurred on February 27, 2024.

What was Astrana Health, Inc.'s former name?

Astrana Health, Inc. was formerly known as Apollo Medical Holdings, Inc.

In which state is Astrana Health, Inc. incorporated?

Astrana Health, Inc. is incorporated in Delaware.

What is the business address of Astrana Health, Inc.?

The business address of Astrana Health, Inc. is 1668 S. Garfield Avenue, 2nd Floor, Alhambra, California 91801.

Filing Stats: 560 words · 2 min read · ~2 pages · Grade level 10 · Accepted 2024-02-27 16:19:15

Filing Documents

02

Item 2.02 Results of Operations and Financial Condition. On February 27, 2024, Astrana Health, Inc. (the "Company") issued a press release announcing its financial results for the three and twelve months ended December 31, 2023. A copy of the press release and supplemental data is furnished with this Current Report on Form 8-K as Exhibit 99.1 and Exhibit 99.2 , respectively, and incorporated herein by this reference. In accordance with General Instruction B.2 of Form 8-K, the information furnished pursuant to this Item 2.02, including Exhibit 99.1 and Exhibit 99.2 furnished herewith, shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.

Financial Statements and Exhibits

Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 99.1 Press Release of Astrana Health, Inc. Regarding its Financial Results for the Three and Twelve Months Ended December 31, 2023, dated February 27, 2024. 99.2 Supplemental Data of Astrana Health, Inc., dated February 27, 2024. 104 Cover Page Interactive Data File (the cover page XBRL tags are embedded within the inline XBRL document).

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ASTRANA HEALTH, INC. Date: February 27, 2024 By: /s/ Brandon Sim Name: Brandon Sim Title: Chief Executive Officer and President

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing